Earnings History Data for VistaGen Therapeutics, Inc. (VTGN) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

VistaGen Therapeutics, Inc.

VistaGen Therapeutics, Inc. is a biotechnology company. It is engaged in developing and commercializing product candidates for diseases and disorders involving the central nervous system. The company's lead product candidate consists of AV-101, is an orally available prodrug candidate in Phase II development, initially for the adjunctive treatment of major depressive disorder. VistaGen Therapeutics, Inc. is headquartered in South San Francisco, California.
Release Date Time Est. Time Symbol Name Market Cap (M) Rep. EPS Est. EPS Last years EPS SeekingAlpha Headline Price Change Ext. Hours Price Ext. Hours Change 52 Week Range Volume Avg. Volume Ext. Hours Volume Top Mover
23-06-2022 AH 4:20 PM ET
(Jun 23)
VTGN VistaGen Therapeutics, Inc. 218.92 -0.08 -0.06 -0.20 VistaGen Therapeutics GAAP EPS of -$0.25 misses by $0.03, revenue of $1.11M misses by $0.21M
[6/23/2022 4:22 PM]
0.9679 -0.07 
(-6.93%)
1.02 -0.02 
(-1.92%)
0.87 - 3.55 2,080,145 1,180,000 5,615
10-02-2022 AH 4:20 PM ET
(Feb 10)
VTGN VistaGen Therapeutics, Inc. 311.54 -0.05 -0.08 -0.07 VistaGen Therapeutics GAAP EPS of -$0.05 beats by $0.02, revenue of $0.36M beats by $0.11M
[2/10/2022 4:32 PM]
1.51 -0.03 
(-1.95%)
1.64 0.10 
(6.49%)
1.40 - 3.55 1,437,833 1,350,000 4,617
10-11-2021 AH 4:25 PM ET
(Nov 10)
VTGN VistaGen Therapeutics, Inc. 476.47 -0.07 -0.05 -0.05 VistaGen Therapeutics EPS misses by $0.01, beats on revenue
[11/10/2021 4:28 PM]
2.35 0.10 
(4.44%)
2.27 0.02 
(0.89%)
0.65 - 3.55 3,053,487 1,170,000 421
12-08-2021 AH 4:15 PM ET
(Aug 12)
VTGN VistaGen Therapeutics, Inc. 530.19 -0.04 -0.05 -0.07 VistaGen Therapeutics EPS beats by $0.01, misses on revenue
[8/12/2021 4:36 PM]
2.78 0.03 
(1.09%)
2.75 0.0 
(0.00%)
0.56 - 3.55 918,048 830,000 690
29-06-2021 AH VTGN Vistagen Therapeutics, Inc. 377.00 -0.20 -0.05 0.00 VistaGen Therapeutics EPS misses by $0.27, beats on revenue
[6/29/2021 4:17 PM]
3.17 0.49 
(18.28%)
2.69 0.01 
(0.37%)
0.46 - 3.18 6,844,214 4,650,000 20,686
11-02-2021 AH VTGN VistaGen Therapeutics, Inc. 261.85 -0.07 -0.05 -0.15 VistaGen Therapeutics EPS misses by $0.02, beats on revenue
[2/11/2021 4:54 PM]
1.90 -0.08 
(-4.04%)
1.98 0.0 
(0.00%)
0.30 - 2.94 2,448,488 2,554,831 42,576
12-11-2020 AH VTGN VistaGen Therapeutics, Inc. 48.17 -0.05 0.02 -0.13 VistaGen Therapeutics EPS of -$0.05
[11/12/2020 5:41 PM]
0.70 0.0 
(-0.37%)
0.70 0.0 
(-0.37%)
0.29 - 1.15 217,681 507,776 13,115